Ranibizumab for Neovascular Age-Related Macular Degeneration
Intravitreal administration of ranibizumab for 2 years prevented vision loss and improved mean visual acuity, with low rates of serious adverse events, in patients with minimall...
Publications
1 shownFrequent Co-Authors
Researcher Info
- h-index
- 1
- Publications
- 1
- Citations
- 5,737
- Institution
- Retina Vitreous Associates Medical Group
External Links
Identifiers
- ORCID
- 0000-0001-9219-1614
Impact Metrics
h-index
1
h-index: Number of publications with at least h citations each.